Hemispherx BioPharma Inc.
(Public, AMEX:HEB)
At approximately 3:30pm EST, 5/29/09, StocksHaven Investments began the call conference scheduled with Chairman & CEO of Hemispherx BioPharma Inc., Dr. William Carter. The basis interview was with regards to TheStreet.com‘s Adam Feuerstein‘s recent article, “Hemispherx’s CFS Drug Is a Long Shot“. The interview was concluded as of 4:00pm EST, 5/29/09. Many issues and concerns of private individual investors were raised and answered in a both informative and intellectual manner by Dr. Carter.
The exclusive StocksHaven Investments interview:
If you are experiencing technical difficulties, please visit this link. You will be taken to the original source of the mp3 file where your automatic preset media player should make the file play.
Update: For best results please use Mozilla Firefox version 3.0.10 web browser
In addition, StocksHaven Investments would like to thank all of the contributors who have helped facilitate and assist with this conference.
|
About Michael: A young and savvy, yet experienced and accomplished investments mogul since ‘01; Michael has amassed a fortune as a private self investor. Recently starting his own successful blog and turning it in to a corporation — MIV Investments Inc., a company offering advice to thousands of people worldwide and attracting contracts from various reputable sources. His articles and publications have been linked to Forbes, CNN Money, Reuters, Bloomberg, and many other top worldwide mainstream media sources. |




